Exemestane Prescribing at ROTHSCHILD HOUSE GROUP
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
183
Total Quantity
4,782
NHS Cost
£1.3K
vs National Avg
+463.2%
ROTHSCHILD HOUSE GROUP prescribed 183 items of Exemestane over the last 12 months at a cost of £1,263 to the NHS. This is 463.2% above the national average prescribing rate. Exemestane is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jun 2026
15
Jun 2026
14
Jun 2026
10
Jun 2026
15
Jun 2026
15
Jun 2026
14
Jun 2026
25
Jun 2026
19
Jun 2026
17
Jun 2026
18
Jun 2026
14
Jun 2026
7
Prescribing Details
| Total Items | 183 |
|---|---|
| Total Quantity | 4,782 |
| Total NHS Cost | £1,263 |
| Presentations | 2 different forms |
| vs National Average | +463.2% |
Exemestane Prescribing Comparison
| This practice | 183 items |
|---|---|
| National average per practice | 33 items |
| Difference | +463.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.